Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 25, 2026, United Therapeutics Corporation issued a press release setting forth its earnings and bus
. Exhibits This information shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise su